U.S. Patent and Trademark Office Releases Optipharm Co Ltd's Patent Application for Transgenic Cloned Pig for Xenotransplantation Expressing Human CD46 and TBM Genes, in Which Porcine Endogenous Retrovirus Envelope C is Negative and GGTA1, CMAH, iGb3s and

Press/Media: Press / Media

Period2022 Aug 13

Media coverage

1

Media coverage

  • TitleU.S. Patent and Trademark Office Releases Optipharm Co Ltd's Patent Application for Transgenic Cloned Pig for Xenotransplantation Expressing Human CD46 and TBM Genes, in Which Porcine Endogenous Retrovirus Envelope C is Negative and GGTA1, CMAH, iGb3s and
    Media name/outletGlobal IP News. Biotechnology Patent News
    Country/TerritoryIndia
    Date22/8/13
    Personsjin woo Park